+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Market by Product Type, Application, Distribution Channel, End User - Global Forecast to 2030- Product Image
Women's Health Market by Product Type, Application, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Women's Health Market by Product Type, Application, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666341
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Women's Health Market grew from USD 46.99 billion in 2024 to USD 51.36 billion in 2025. It is expected to continue growing at a CAGR of 9.03%, reaching USD 78.98 billion by 2030.

Pioneering Insights Shaping the Future of Women's Health

Women’s health has emerged as one of the most dynamic domains in contemporary healthcare, driven by evolving patient priorities, technological breakthroughs, and regulatory evolution. This report synthesizes the complex interplay of factors shaping the landscape, from cutting-edge product innovations to shifting policy frameworks. It begins by contextualizing the critical importance of interventions across the lifecycle-from fertility planning to menopause support-and underscores the pivotal role of integrated solutions in improving outcomes and quality of life.

By weaving together clinical insights, industry developments, and patient-centric considerations, the introduction establishes a clear foundation for deeper exploration. It highlights the urgency of addressing persistent gaps in access and affordability while celebrating advances that enhance personalization and preventive care. From the rising adoption of digital health platforms to the expansion of minimally invasive procedures, this section frames the narrative for subsequent analysis, emphasizing why stakeholders must stay attuned to emerging trends and data-driven strategies. The introduction sets the stage for actionable insights, enabling decision-makers to anticipate challenges, leverage opportunities, and chart pathways toward sustainable growth.

Unveiling Transformative Shifts Reshaping Care Delivery

The women’s health ecosystem is undergoing transformative shifts that reflect broader societal changes and technological maturation. Consumer empowerment now drives service delivery models, as digital engagement platforms, telehealth solutions, and personalized medicine gain traction. These developments are complemented by a renewed focus on holistic wellness, integrating mental health, nutrition, and lifestyle management into conventional care pathways.

In parallel, regulatory bodies are recalibrating frameworks to expedite approvals while maintaining rigorous safety standards. This evolution accelerates time to market for innovative therapies, from next-generation hormone replacement modalities to advanced fertility monitoring devices. Collaboration between industry and academia fosters translational research, resulting in a pipeline of targeted treatments and diagnostic tools designed for precision application. As a result, stakeholders must embrace agility and cross-functional synergy to navigate a landscape where value-based care and outcome-driven models define success.

Assessing the Ripple Effects of US Tariffs on Market Dynamics

The implementation of United States tariffs in 2025 has introduced significant headwinds across the women’s health supply chain, influencing both cost structures and strategic sourcing decisions. Manufacturers reliant on imported raw materials and medical components have faced escalated input costs that reverberate through pricing strategies and profit margins. In response, companies have reevaluated global procurement networks, pursuing regional hubs and near-shoring arrangements to mitigate exposure and maintain continuity of supply.

Moreover, these tariffs have prompted pricing recalibrations across distribution channels, driving some providers to absorb incremental expenses while others have passed costs onto end users. This dynamic has underscored the importance of value communication and differentiation, with leading players enhancing service bundles to justify premium positioning. As market participants adapt, a two-tiered environment emerges: those able to optimize cost efficiencies through scale and operational excellence, and smaller entities that may face margin compression unless they adopt agile sourcing models and strategic partnerships. Understanding the cumulative impact of these measures is essential for forecasting competitive positioning and investment priorities.

Revealing Nuanced Segmentation Patterns Driving Growth

Detailed segmentation illuminates the nuanced drivers of demand and adoption across diverse product categories, applications, channels, and end-user groups. The market’s product dimension captures a spectrum that spans barrier, implantable, injectable, intrauterine and oral contraceptives-including combined, extended cycle and progestin-only formulations-alongside fertility monitoring devices such as basal body thermometers, trackers and ovulation tests. Maternal care offerings encompass fetal monitoring technologies, postnatal nutritional supplements, pregnancy test kits and prenatal vitamins, while menopause support integrates hormone therapies, nonhormonal treatments and dietary supplements. Menstrual health is addressed through cups, panty liners, sanitary pads and tampons, each tailored to specific user preferences.

When viewed through the lens of application, demand patterns segment into fertility enhancement, gynecological procedures, hormonal imbalance treatments, menstrual disorder management and overarching reproductive health initiatives. Distribution dynamics reveal a competitive interplay among direct sales, digital commerce platforms, hospital and online pharmacies, as well as traditional retail outlets. Finally, end-user segmentation differentiates clinics, homecare settings, hospitals and individual consumers, underscoring the need for tailored engagement strategies and service models that accommodate diverse care environments and patient journeys.

Mapping Regional Divergence in Service and Product Adoption

Regional analysis highlights distinct trajectories in market evolution, shaped by economic, regulatory and cultural factors. In the Americas, robust public and private investments have fueled widespread access to contraceptives, fertility services and maternal care programs, complemented by mature reimbursement frameworks and integrated healthcare networks. Meanwhile, Europe, Middle East & Africa present a mosaic of regulatory environments that range from highly structured health systems with centralized procurement to emerging markets prioritizing infrastructure development and mobile health solutions. This region’s heterogeneity offers both challenges and entry points for innovators.

Asia-Pacific stands out for its rapid urbanization, rising middle-class demographics and increasing digital adoption, which drive demand for personalized and technology-enabled health tools. Governments across these markets are launching ambitious women’s health initiatives, bolstering awareness and reducing stigma around reproductive and gynecological conditions. Collectively, the geographic insights extend vital context for prioritizing market entry, partnership formation and investment allocation.

Spotlight on Industry Trailblazers and Innovators

Several leading enterprises are shaping the competitive landscape through robust R&D pipelines, strategic collaborations and targeted acquisitions. Bayer has intensified its focus on next-generation contraceptives, investing in novel delivery mechanisms and digital adherence programs. CooperSurgical leverages its breadth in fertility and maternal care to deliver integrated solutions supported by analytics platforms. Medtronic’s expertise in advanced monitoring technologies underscores its commitment to precision maternal and gynecological care, while Baxter is expanding nonhormonal therapeutic options and supplement portfolios to address menopause and menstrual health.

Smaller innovators are also influencing market dynamics by championing disruptive approaches, from on-demand hormone assays to AI-driven ovulation forecasting. Partnerships between global players and regional specialists facilitate market access and accelerate localization of offerings. Collectively, these activities underscore an environment where agility, investment in evidence generation and cross-sector collaboration determine leadership and differentiation.

Actionable Strategies for Leaders to Navigate Emerging Trends

Industry leaders should prioritize integrated digital-physical care models that enhance patient engagement and data-driven personalization. Establishing strategic alliances with technology providers can turbocharge product development cycles and foster interoperability across platforms. To safeguard margins amid cost pressures, organizations must optimize supply chains by diversifying sourcing, adopting lean manufacturing practices and exploring contract manufacturing partnerships.

Furthermore, robust evidence generation through real-world studies and health economics analyses will strengthen value propositions and support favorable reimbursement outcomes. Market entrants should concentrate on underserved segments-such as nonhormonal menopause options or low-cost fertility monitoring solutions-to capture untapped demand. Finally, cultivating patient advocacy and education initiatives can drive brand loyalty and improve adoption, ensuring that business models align with evolving expectations for transparency and empowerment.

Rigorous Methodology Underpinning Market Intelligence

This research draws upon a multifaceted methodology designed to ensure rigor, validity and actionable insights. Secondary data was synthesized from peer-reviewed journals, regulatory filings, patent databases and industry reports. Primary research involved in-depth interviews with key opinion leaders, healthcare providers, payers and end-users, supplemented by surveys that captured qualitative and quantitative dimensions of market perception.

Data triangulation was applied to reconcile disparities and validate emerging trends, while thematic analysis identified core drivers of innovation and adoption. Market segmentation was conducted using a bottom-up approach, mapping demand patterns across product categories, applications, channels and end-user groups. Regional insights were refined through country-level assessments of policy frameworks, reimbursement landscapes and competitive dynamics. Quality assurance protocols included peer review by subject matter experts and iterative validation workshops with internal analysts to eliminate bias and ensure clarity.

Synthesizing Insights to Guide Informed Decision Making

In synthesizing these insights, the report illuminates how evolving technologies, regulatory shifts and consumer expectations converge to redefine women’s health. Stakeholders equipped with this intelligence can adeptly navigate tariff-related challenges, calibrate product portfolios to segmentation nuances and align regional strategies with local imperatives. The narrative underscores the interplay between innovation speed and evidence generation as the cornerstone of competitive differentiation.

Ultimately, organizations that integrate patient-centric design, strategic foresight and operational resilience will realize sustained growth and deliver meaningful health outcomes. This holistic perspective offers a roadmap for decision-makers seeking to optimize investments, enhance value delivery and foster inclusive access across the full spectrum of women’s healthcare.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Contraceptives
      • Barrier Contraceptives
        • Diaphragms
        • Female Condoms
        • Male Condoms
      • Implants
      • Injectable Contraceptives
      • Intrauterine Devices
      • Oral Contraceptives
        • Combined Pill
        • Extended Cycle Pill
        • Progestin Only Pill
    • Fertility Monitoring Devices
      • Basal Body Thermometers
      • Fertility Trackers
      • Ovulation Test Kits
    • Maternal Care
      • Fetal Monitoring Devices
      • Postnatal Supplements
      • Pregnancy Test Kits
      • Prenatal Vitamins
    • Menopause Support
      • Hormone Replacement Therapies
      • Nonhormonal Therapeutics
      • Supplements
    • Menstrual Health Products
      • Menstrual Cups
      • Panty Liners
      • Sanitary Pads
      • Tampons
  • Application
    • Fertility Enhancement
    • Gynecological Procedures
    • Hormonal Imbalance Treatment
    • Menstrual Disorder Management
    • Reproductive Health
  • Distribution Channel
    • Direct Sales
    • E-Commerce Platforms
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Clinics
    • Homecare Settings
    • Hospitals
    • Individual Consumers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Ferring International Center S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Organon & Co.
  • AbbVie Inc.
  • Novartis AG
  • Roche Holding AG
  • Amgen Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Women's Health Market, by Product Type
8.1. Introduction
8.2. Contraceptives
8.2.1. Barrier Contraceptives
8.2.1.1. Diaphragms
8.2.1.2. Female Condoms
8.2.1.3. Male Condoms
8.2.2. Implants
8.2.3. Injectable Contraceptives
8.2.4. Intrauterine Devices
8.2.5. Oral Contraceptives
8.2.5.1. Combined Pill
8.2.5.2. Extended Cycle Pill
8.2.5.3. Progestin Only Pill
8.3. Fertility Monitoring Devices
8.3.1. Basal Body Thermometers
8.3.2. Fertility Trackers
8.3.3. Ovulation Test Kits
8.4. Maternal Care
8.4.1. Fetal Monitoring Devices
8.4.2. Postnatal Supplements
8.4.3. Pregnancy Test Kits
8.4.4. Prenatal Vitamins
8.5. Menopause Support
8.5.1. Hormone Replacement Therapies
8.5.2. Nonhormonal Therapeutics
8.5.3. Supplements
8.6. Menstrual Health Products
8.6.1. Menstrual Cups
8.6.2. Panty Liners
8.6.3. Sanitary Pads
8.6.4. Tampons
9. Women's Health Market, by Application
9.1. Introduction
9.2. Fertility Enhancement
9.3. Gynecological Procedures
9.4. Hormonal Imbalance Treatment
9.5. Menstrual Disorder Management
9.6. Reproductive Health
10. Women's Health Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. E-Commerce Platforms
10.4. Hospital Pharmacies
10.5. Online Pharmacies
10.6. Retail Pharmacies
11. Women's Health Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Homecare Settings
11.4. Hospitals
11.5. Individual Consumers
12. Americas Women's Health Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Women's Health Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Women's Health Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Pfizer Inc.
15.3.3. Merck & Co., Inc.
15.3.4. Ferring International Center S.A.
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. Organon & Co.
15.3.7. AbbVie Inc.
15.3.8. Novartis AG
15.3.9. Roche Holding AG
15.3.10. Amgen Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. WOMEN'S HEALTH MARKET MULTI-CURRENCY
FIGURE 2. WOMEN'S HEALTH MARKET MULTI-LANGUAGE
FIGURE 3. WOMEN'S HEALTH MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. WOMEN'S HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIAPHRAGMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MALE CONDOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COMBINED PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY EXTENDED CYCLE PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PROGESTIN ONLY PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY BASAL BODY THERMOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY TRACKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY OVULATION TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FETAL MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POSTNATAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PREGNANCY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRENATAL VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY NONHORMONAL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL CUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PANTY LINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY SANITARY PADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY TAMPONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GYNECOLOGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL IMBALANCE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL DISORDER MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 87. CANADA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 88. CANADA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 89. CANADA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 90. CANADA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 91. CANADA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 92. CANADA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 93. CANADA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. CANADA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 103. MEXICO WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. MEXICO WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 156. GERMANY WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 157. GERMANY WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 159. GERMANY WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. GERMANY WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. FRANCE WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 165. FRANCE WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 166. FRANCE WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 167. FRANCE WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 168. FRANCE WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 170. FRANCE WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FRANCE WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. ITALY WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. ITALY WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 187. ITALY WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 188. ITALY WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 189. ITALY WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. ITALY WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 191. ITALY WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 192. ITALY WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 193. ITALY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. ITALY WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SPAIN WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 198. SPAIN WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 199. SPAIN WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 200. SPAIN WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 201. SPAIN WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 203. SPAIN WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 204. SPAIN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SPAIN WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. DENMARK WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. DENMARK WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 242. DENMARK WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 243. DENMARK WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 244. DENMARK WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 245. DENMARK WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 246. DENMARK WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 247. DENMARK WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 248. DENMARK WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. DENMARK WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. DENMARK WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. QATAR WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. QATAR WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 264. QATAR WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 265. QATAR WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 266. QATAR WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 267. QATAR WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 268. QATAR WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 269. QATAR WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 270. QATAR WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. QATAR WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. QATAR WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. FINLAND WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 275. FINLAND WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 276. FINLAND WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 277. FINLAND WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 278. FINLAND WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 279. FINLAND WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 280. FINLAND WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 281. FINLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. FINLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. FINLAND WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. EGYPT WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. EGYPT WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 308. EGYPT WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 309. EGYPT WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 310. EGYPT WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 311. EGYPT WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 312. EGYPT WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 313. EGYPT WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 314. EGYPT WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. EGYPT WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. EGYPT WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. TURKEY WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. TURKEY WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 319. TURKEY WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 320. TURKEY WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 321. TURKEY WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 322. TURKEY WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 323. TURKEY WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 324. TURKEY WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 325. TURKEY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. TURKEY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. TURKEY WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY MATERNAL CARE, 2018-2030 (USD MILLION)
TABLE 334. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE SUPPORT, 2018-2030 (USD MILLION)
TABLE 335. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL HEALTH PRODUCTS, 2018-2030 (USD MILLION)
TABLE 336. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. NORWAY WOMEN'S HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. NORWAY WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 341. NORWAY WOMEN'S HEALTH MARKET SIZE, BY BARRIER CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 342. NORWAY WOMEN'S HEALTH MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 343. NORWAY WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 344. NORWAY WOMEN'S HEALTH MARKET SI

Companies Mentioned

The companies profiled in this Women's Health market report include:
  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Ferring International Center S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Organon & Co.
  • AbbVie Inc.
  • Novartis AG
  • Roche Holding AG
  • Amgen Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 51.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 78.98 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Women's Health Market Report 2025 - Product Image

Women's Health Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Women Health & Beauty Supplements Market by Product Type, Form, Age Groups, Consumer Type, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Women Health & Beauty Supplements Market by Product Type, Form, Age Groups, Consumer Type, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Women's Health Therapeutics Market by Therapeutic Area, Product Type, Distribution Channel, End-User - Global Forecast to 2030 - Product Image

Women's Health Therapeutics Market by Therapeutic Area, Product Type, Distribution Channel, End-User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030 - Product Image

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Women's Health Market

The Women's Health market is a sector of the healthcare industry that focuses on the health and wellness of women. It includes products and services that are designed to meet the unique needs of women, such as contraception, fertility treatments, and menopause management. It also includes products and services that are designed to improve the overall health and wellbeing of women, such as nutrition, exercise, and mental health. The Women's Health market is growing rapidly, driven by increasing awareness of the importance of women's health and wellness, as well as advances in technology and healthcare. Companies in this market include pharmaceutical companies, medical device manufacturers, health and wellness companies, and digital health companies. Examples of companies in this market include Bayer, Merck, Pfizer, Novo Nordisk, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.